SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000950142-07-000537
Filing Date
2007-02-14
Accepted
2007-02-14 11:16:46
Documents
1
Group Members
FRANK H. PEARLGEORGE SOROSPERSEUS BIOTECH FUND PARTNERS, LLCPERSEUS-SOROS BIOPHARMACEUTICAL FUND, L.P.PERSEUS-SOROS PARTNERS, LLCPERSEUSPUR, LLCSFM AH LLCSFM PARTICIPATION, L.P.SOROS FUND MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g_replidyne.txt SC 13G 44947
  Complete submission text file 0000950142-07-000537.txt   47167
Mailing Address 888 SEVENTH AVE 30TH FL NEW YORK NY 10106
Business Address ARMY & NAVY CLUB BLDG 1627 I ST NW STE 610 WASHINGTON DC 20006 (212) 651-6389
PERSEUS SOROS BIOPHARMACEUTICAL FUND LP (Filed by) CIK: 0001111408 (see all company filings)

IRS No.: 000000000
Type: SC 13G

Mailing Address
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 303-665-3450
REPLIDYNE INC (Subject) CIK: 0001180145 (see all company filings)

IRS No.: 000000000
Type: SC 13G | Act: 34 | File No.: 005-81890 | Film No.: 07615454
SIC: 2834 Pharmaceutical Preparations